Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Exploratory Open Label, Randomized Study of Acetyl- and Propionylcarnitine in Chronic Fatigue Syndrome

Bibliographic Data

ID19301968
AuthorsRuud C W Vermeulen, Ruud CW Vermeulen (Amsterdam University of Applied Sciences, corresponding author), Hans R Scholte
Year2004
Volume66
Issue2
Pages276-282
Publication date2004-03-01
Open AccessNo
TypeARTICLE
VenuePsychosomatic Medicine (JOURNAL)
Journal identifiersISSN: 0033-3174 • E-ISSN: 1534-7796
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/01.psy.0000116249.60477.e9
PMID15039515
OpenAlexW2047514097
LanguageEN
Citations received2
References cited26

OBJECTIVES: We compared the effects of acetylcarnitine, propionylcarnitine and both compounds on the symptoms of chronic fatigue syndrome (CFS). METHODS: In an open, randomized fashion we compared 2 g/d acetyl-L-carnitine, 2 g/d propionyl-L-carnitine, and its combination in 3 groups of 30 CFS patients during 24 weeks. Effects were rated by clinical global impression of change. Secondary endpoints were the Multidimensional Fatigue Inventory, McGill Pain Questionnaire, and the Stroop attention concentration test. Scores were assessed 8 weeks before treatment; at randomization; after 8, 16, and 24 weeks of treatment; and 2 weeks later. RESULTS: Clinical global impression of change after treatment showed considerable improvement in 59% of the patients in the acetylcarnitine group and 63% in the propionylcarnitine group, but less in the acetylcarnitine plus propionylcarnitine group (37%). Acetylcarnitine significantly improved mental fatigue (p =.015) and propionylcarnitine improved general fatigue (p =.004). Attention concentration improved in all groups, whereas pain complaints did not decrease in any group. Two weeks after treatment, worsening of fatigue was experienced by 52%, 50%, and 37% in the acetylcarnitine, propionylcarnitine, and combined group, respectively. In the acetylcarnitine group, but not in the other groups, the changes in plasma carnitine levels correlated with clinical improvement. CONCLUSIONS: Acetylcarnitine and propionylcarnitine showed beneficial effect on fatigue and attention concentration. Less improvement was found by the combined treatment. Acetylcarnitine had main effect on mental fatigue and propionylcarnitine on general fatigue

Acetylcarnitine · Carnitine · Randomization · Randomized controlled trial · Fibromyalgia and Chronic Fatigue Syndrome Research · Genetic Neurodegenerative Diseases · Internal Medicine · Medicine · Psychology · Sleep and related disorders

  • Epidemiological study air disaster in Amsterdam (Esada)

    Open Access•Pauline Slottje, Anja C Huizink et al.•BMC Public Health•2005

  • Criteria Used to Define Chronic Fatigue Syndrome Questioned

    Tom Kindlon•Psychosomatic Medicine•2010

  • The Chronic Fatigue Syndrome

    Open Access•Keiji Fukuda, STEPHEN E STRAUS et al.•Annals of Internal Medicine•1994

Citations per year0.1
Citation span2005 - 2010 (6)
Highly citedNo

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae